| Name | Title | Contact Details |
|---|---|---|
Chris Carlson |
Sr Vice President Customer Experience and Complex Health Solutions | Profile |
Linda Jones |
Chief Client Officer | Profile |
Kristie Lundy |
Vice President, Financial Protection Products | Profile |
Susan Farrell |
Vice President Product Marketing | Profile |
Sandeep Nandi |
Vice President Of Products | Profile |
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
Wagoner Community Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Wagoner, OK. To find more information about Wagoner Community Hospital, please visit www.wagonerhospital.com
Brasseler USA is a Savannah, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DUOS is reimagining freedom at any age. As a technology-enabled service provider, DUOS connects people to the essential resources required to attain the highest level of health. Our advanced technology allows us to aggregate historically siloed data and resources from across the ecosystem, breaking down barriers to health literacy and access to care and enabling seamless and timely connections with complete visibility and feedback throughout the process.